Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged &#8805;70 years.

Lachowiez, Curtis; Cook, Rachel J; Hayes-Lattin, Brandon; Maziarz, Richard T; Borate, Uma; Traer, Elie; Leonard, Jessica; Newell, Laura; Dao, Kim-Hien; Meyers, Gabrielle

Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years.

Lachowiez, Curtis; Cook, Rachel J; Hayes-Lattin, Brandon; Maziarz, Richard T; Borate, Uma; Traer, Elie; Leonard, Jessica; Newell, Laura; Dao, Kim-Hien; Meyers, Gabrielle.

Afiliação

Lachowiez C; Department of Medicine, Oregon Health and Science University, Portland, OR, USA. Electronic address: lachowiez@ohsu.edu.
Cook RJ; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Hayes-Lattin B; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Maziarz RT; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Borate U; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Traer E; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Leonard J; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Newell L; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Dao KH; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Meyers G; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.

Hematol Oncol Stem Cell Ther ; 12(2): 105-109, 2019 Jun.

Article em En | MEDLINE | ID: mdl-30836091

Assuntos

Transplante de Células-Tronco Hematopoéticas; Leucemia Mieloide Aguda/mortalidade; Leucemia Mieloide Aguda/terapia; Síndromes Mielodisplásicas/mortalidade; Síndromes Mielodisplásicas/terapia; Idoso; Aloenxertos; Intervalo Livre de Doença; Feminino; Humanos; Leucemia Mieloide Aguda/patologia; Masculino; Síndromes Mielodisplásicas/patologia; Taxa de Sobrevida

Palavras-chave

Acute Myeloid Leukemia; Allogeneic Stem Cell Transplant; Bone Marrow Transplant; FLT-3; Hypomethylating agent; Induction Chemotherapy; Leukemia; Myelodysplastic syndrome; Targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Mortalidade / Geral / Tipos_de_cancer / Leucemia / Tratamento Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Hematol Oncol Stem Cell Ther Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google